Claudia Hui
Role: Investigator
Sites: CDL-Toronto, CDL-Vancouver
Stream: Advanced Therapies
Claudia Hui is a Director at Bloom Burton & Co, Canada’s leading healthcare-focused investment bank. She joined the firm as an Analyst in 2015 and has since taken on increasingly progressive roles. Claudia’s expertise helps identify and unlock value in healthcare companies. She provides monetization planning, strategic advisory services and conducts technical and commercial due diligence for companies across all healthcare sectors and stages of development. She also leads the firm’s initiatives in identifying and supporting emerging high-growth MedTech companies.
Claudia serves on the Business and Community Advisory Board of the Centre for Discovery in Cancer Research, advising on translation, fundraising, and partnerships, and previously served on the Intellectual Property Advisory Committee for AllerGen NCE Inc. from 2017 to 2020.
Claudia holds a PhD in Infection and Immunity with a focus on allergy and immunology and a MSc in Physiology and Pharmacology, both from McMaster University, as well as a BSc in Physiology from McGill University.